SAIA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Saia Inc (SAIA) is not a strong buy for a beginner investor with a long-term strategy at this moment. While the company has shown some positive revenue trends and hedge funds are increasing their positions, the financial performance in the latest quarter is weak, with significant declines in net income and EPS. Additionally, the options data reflects a bearish sentiment, and analyst ratings are mixed with some downgrades. The technical indicators are neutral to slightly bullish, but the stock does not present a compelling entry point for long-term investment given the current data.
The technical indicators show a mixed picture. The MACD is above zero but positively contracting, suggesting weakening momentum. The RSI is neutral at 46.655, and the moving averages are bullish (SMA_5 > SMA_20 > SMA_200). Key support and resistance levels are at 347.493 and 411.371, respectively. The stock is trading near its pivot point of 379.432, indicating no strong directional bias.
Hedge funds are significantly increasing their positions, with a 1241.86% increase in buying over the last quarter. Analysts have raised price targets, with some projecting values as high as $493.
The company's Q4 2025 financial performance showed a significant decline in net income (-37.56%) and EPS (-37.46%) YoY. Elevated costs remain a concern, and analysts have mixed ratings, with some downgrades citing weak growth and risks to future earnings. Options data reflects bearish sentiment, and insiders are neutral with no significant activity.
In Q4 2025, Saia reported a slight revenue increase of 0.13% YoY to $790 million. However, net income dropped by 37.56% YoY to $47.52 million, and EPS fell by 37.46% YoY to $1.77. Gross margin also declined by 2.91% YoY to 64.39%. These results indicate weak profitability and growth trends.
Analyst ratings are mixed. While several firms raised their price targets (e.g., UBS to $493, Stephens to $445), others downgraded the stock (e.g., Morgan Stanley to Underweight with a $250 target). Analysts are concerned about elevated costs and weak growth, but some see potential for improvement in 2026.
